skip to main content
Idioma:
Resultados 1 2 3 next page
Refinado por: assunto: Pharmacogenetics remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pharmacogenetics to guide cardiovascular drug therapy
Pharmacogenetics to guide cardiovascular drug therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacogenetics to guide cardiovascular drug therapy

Duarte, Julio D ; Cavallari, Larisa H

Nature reviews cardiology, 2021-09, Vol.18 (9), p.649-665 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans
Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans

Hernandez, W ; Gamazon, E R ; Aquino-Michaels, K ; Patel, S ; O'Brien, T J ; Harralson, A F ; Kittles, R A ; Barbour, A ; Tuck, M ; McIntosh, S D ; Douglas, J N ; Nicolae, D ; Cavallari, L H ; Perera, M A

The pharmacogenomics journal, 2014-06, Vol.14 (3), p.223-228 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Anticoagulation Endpoints With Clinical Implementation of Warfarin Pharmacogenetic Dosing in a Real‐World Setting: A Proposal for a New Pharmacogenetic Dosing Approach
Anticoagulation Endpoints With Clinical Implementation of Warfarin Pharmacogenetic Dosing in a Real‐World Setting: A Proposal for a New Pharmacogenetic Dosing Approach
Material Type:
Artigo 		Adicionar ao Meu Espaço

Anticoagulation Endpoints With Clinical Implementation of Warfarin Pharmacogenetic Dosing in a Real‐World Setting: A Proposal for a New Pharmacogenetic Dosing Approach

Arwood, MJ ; Deng, J ; Drozda, K ; Pugach, O ; Nutescu, EA ; Schmidt, S ; Duarte, JD ; Cavallari, LH

Clinical pharmacology and therapeutics, 2017-05, Vol.101 (5), p.675-683 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
4
Feasibility of preemptive pharmacogenetic testing and improvement of medication treatment satisfaction among medically underserved patients
Feasibility of preemptive pharmacogenetic testing and improvement of medication treatment satisfaction among medically underserved patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Feasibility of preemptive pharmacogenetic testing and improvement of medication treatment satisfaction among medically underserved patients

Lteif, Christelle ; Eddy, Elizabeth ; Terrell, Joshua ; Cavallari, Larisa H. ; Malaty, John ; Duarte, Julio D.

Clinical and translational science, 2024-01, Vol.17 (1), p.e13692-n/a [Periódico revisado por pares]

United States: John Wiley and Sons Inc

Texto completo disponível

Citações Citado por
5
CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings
CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings
Material Type:
Artigo 		Adicionar ao Meu Espaço

CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings

Beitelshees, Amber L ; Thomas, Cameron D ; Empey, Philip E ; Stouffer, George A ; Angiolillo, Dominick J ; Franchi, Francesco ; Tuteja, Sony ; Limdi, Nita A ; Lee, James C ; Duarte, Julio D ; Kreutz, Rolf P ; Skaar, Todd C ; Coons, James C ; Giri, Jay ; McDonough, Caitrin W ; Rowland, Rachel ; Stevenson, James M ; Thai, Thuy ; Vesely, Mark R ; Wellen, Jacob T ; Johnson, Julie A ; Winterstein, Almut G ; Cavallari, Larisa H ; Lee, Craig R

Journal of the American Heart Association, 2022-02, Vol.11 (4), p.e024159 [Periódico revisado por pares]

England: John Wiley and Sons Inc

Texto completo disponível

Citações Citado por
6
NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo‐DHF trial
NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo‐DHF trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo‐DHF trial

Dumeny, Leanne ; Vardeny, Orly ; Edelmann, Frank ; Pieske, Burkert ; Duarte, Julio D. ; Cavallari, Larisa H.

Pharmacotherapy, 2021-12, Vol.41 (12), p.978-987 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
7
Pharmacogenetics of P2Y 12 receptor inhibitors
Pharmacogenetics of P2Y 12 receptor inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacogenetics of P2Y 12 receptor inhibitors

Thomas, Cameron D ; Williams, Alexis K ; Lee, Craig R ; Cavallari, Larisa H

Pharmacotherapy, 2023-02, Vol.43 (2), p.158-175 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
8
Implementation of CYP2C19 genotyping to guide proton pump inhibitor use at an academic health center
Implementation of CYP2C19 genotyping to guide proton pump inhibitor use at an academic health center
Material Type:
Artigo 		Adicionar ao Meu Espaço

Implementation of CYP2C19 genotyping to guide proton pump inhibitor use at an academic health center

Cicali, Emily J ; Elchynski, Amanda ; Thomas, Cameron D ; Alam, Benish ; Dalton, Rachel ; Davis, Rick ; Eken, Eda ; Estores, David ; Nguyen, Khoa ; Cavallari, Larisa H ; Wiisanen, Kristin

American journal of health-system pharmacy, 2023-07, Vol.80 (15), p.994-1003 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
9
Pharmacist-guided pharmacogenetic service lowered warfarin-related hospitalizations
Pharmacist-guided pharmacogenetic service lowered warfarin-related hospitalizations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacist-guided pharmacogenetic service lowered warfarin-related hospitalizations

Kim, Kibum ; Duarte, Julio D ; Galanter, William L ; Han, Jin ; Lee, James C ; Cavallari, Larisa H ; Nutescu, Edith A

Pharmacogenomics, 2023-04, Vol.24 (6), p.303-314 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
10
The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting
The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting
Material Type:
Artigo 		Adicionar ao Meu Espaço

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting

Cavallari, LH ; Beitelshees, AL ; Blake, KV ; Dressler, LG ; Duarte, JD ; Elsey, A ; Eichmeyer, JN ; Empey, PE ; Franciosi, JP ; Hicks, JK ; Holmes, AM ; Jeng, LJB ; Lee, CR ; Lima, JJ ; Limdi, NA ; Modlin, J ; Obeng, AO ; Petry, N ; Pratt, VM ; Skaar, TC ; Tuteja, S ; Voora, D ; Wagner, M ; Weitzel, KW ; Wilke, RA ; Peterson, JF ; Johnson, JA

Clinical and translational science, 2017-05, Vol.10 (3), p.143-146 [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2010  (3)
  2. 2010Até2014  (9)
  3. 2015Até2017  (5)
  4. 2018Até2022  (10)
  5. Após 2022  (4)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.